AbbVie (ABBV) on Watch After Amgen (AMGN) Wins FDA Backing for Humira Biosimilar
AbbVie (NYSE: ABBV) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)